Cross Country Healthcare (CCRN) Earning Somewhat Positive News Coverage, Analysis Shows

Media stories about Cross Country Healthcare (NASDAQ:CCRN) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cross Country Healthcare earned a news sentiment score of 0.16 on Accern’s scale. Accern also gave media stories about the business services provider an impact score of 45.3412494222156 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the news articles that may have effected Accern Sentiment’s scoring:

How to Become a New Pot Stock Millionaire

Shares of CCRN traded down $0.11 during midday trading on Friday, reaching $11.11. 73,070 shares of the stock were exchanged, compared to its average volume of 209,973. Cross Country Healthcare has a 52 week low of $9.07 and a 52 week high of $15.09. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $408.77, a price-to-earnings ratio of 18.21, a PEG ratio of 1.99 and a beta of 0.91.

Cross Country Healthcare (NASDAQ:CCRN) last posted its quarterly earnings results on Wednesday, February 28th. The business services provider reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.02). The firm had revenue of $219.67 million for the quarter, compared to the consensus estimate of $225.60 million. Cross Country Healthcare had a return on equity of 10.24% and a net margin of 4.34%. Cross Country Healthcare’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.20 EPS. equities research analysts predict that Cross Country Healthcare will post 0.5 EPS for the current year.

A number of equities analysts have recently issued reports on the company. BidaskClub downgraded Cross Country Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, February 27th. ValuEngine downgraded Cross Country Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. Lake Street Capital reissued a “hold” rating on shares of Cross Country Healthcare in a research report on Friday, March 2nd. Zacks Investment Research raised Cross Country Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, January 9th. Finally, BMO Capital Markets reissued an “outperform” rating and set a $13.00 price target (down previously from $14.00) on shares of Cross Country Healthcare in a research report on Tuesday, March 6th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the stock. Cross Country Healthcare has an average rating of “Hold” and a consensus price target of $15.14.

In related news, CEO William J. Grubbs acquired 10,000 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The stock was purchased at an average cost of $11.18 per share, for a total transaction of $111,800.00. Following the purchase, the chief executive officer now directly owns 353,741 shares of the company’s stock, valued at approximately $3,954,824.38. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director W Larry Cash acquired 5,000 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The shares were bought at an average price of $11.23 per share, with a total value of $56,150.00. Following the completion of the purchase, the director now directly owns 113,580 shares in the company, valued at $1,275,503.40. The disclosure for this purchase can be found here. Corporate insiders own 3.90% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Cross Country Healthcare (CCRN) Earning Somewhat Positive News Coverage, Analysis Shows” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3338981/cross-country-healthcare-ccrn-earning-somewhat-positive-news-coverage-analysis-shows.html.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Insider Buying and Selling by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Dinastycoin Price Reaches $0.0005
Dinastycoin Price Reaches $0.0005
Compcoin Market Capitalization Achieves $0.00
Compcoin Market Capitalization Achieves $0.00
Zacks: ATRION Co.  Given Average Recommendation of “Strong Sell” by Brokerages
Zacks: ATRION Co. Given Average Recommendation of “Strong Sell” by Brokerages
TechShares  Trading 1.3% Higher  Over Last Week
TechShares Trading 1.3% Higher Over Last Week
Abiomed  Expected to Post Earnings of $0.64 Per Share
Abiomed Expected to Post Earnings of $0.64 Per Share
$12.41 Billion in Sales Expected for PepsiCo  This Quarter
$12.41 Billion in Sales Expected for PepsiCo This Quarter


Leave a Reply

© 2006-2018 Ticker Report. Google+.